Press Releases

For Immediate Release on Thursday, December 12, 2019 Northwest Biotherapeutics (OTCQB:NWBO) Further Expands Senior Management Team Executive With Decades of Public and Private Company Experience Joins NW Bio As CFO BETHESDA, Md., December 12, 2019 – Northwest Biotherapeutics (OTCQB: NWBO)(“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that it has further... Read More

For Immediate Release on Wednesday, December 11, 2019 Northwest Biotherapeutics (OTCQB; NWBO) Announces Presentation At Inaugural Glioblastoma Drug Development Summit NW Bio CTO To Highlight History Of DCVax®-L and Phase III Clinical Trial BETHESDA, Md., December 11, 2019 – Northwest Biotherapeutics (OTCQB: NWBO)(“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that... Read More

BETHESDA, MD, October 10, 2019 – Northwest Biotherapeutics (NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that it has entered into a settlement with the SEC.   As previously reported, the Company has been investigated by the SEC and has cooperated with the investigation. The Company has now successfully entered into a settlement agreement with the SEC... Read More

Specialist in Immuno-Oncology; Previously Research Scientific Director In Merck’s Keytruda® Program BETHESDA, MD, September 4, 2019 – Northwest Biotherapeutics (NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that it has expanded its senior management team with the addition of Dr. Kevin T. Duffy as Vice President, Medical Affairs and External... Read More

BETHESDA, Md., June 4, 2019 /PRNewswire/ — Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today highlights from Dr. Marnix Bosch’s Program Update in the Industry Expert Theater presentation at the 55th annual ASCO Conference, which was publicly webcast and was posted on the home page of the Company’s websit... Read More